NCT04161248 2026-05-12Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell LymphomaCanadian Cancer Trials GroupPhase EARLY_PHASE1 Active not recruiting40 enrolled